IDT expands free next-day delivery service
February 14, 2019
LEUVEN, BELGIUM – As an advocate for researchers in the genomics age, Integrated DNA Technologies (IDT) is expanding its courier zones to ensure that the highest-fidelity oligos are available in less time and at the same price, to more customers. UK scientists based in Cambridge, Oxford, and London—both inside and out of the M25 orbital—can now benefit [...]
Global Genomics Leader MGI Expands in Middle East
February 14, 2019
MGI, a subsidiary of BGI Group, announced it is expanding in the Middle East with a new office in Dubai to better serve partners and clients in the region. MGI’s expansion in the region will include UAE, Qatar and Saudi Arabia, serving universities, hospitals, healthcare institutions and other customers and partners throughout the Middle East. [...]
Versatile High-Power LED Photoreactor for Continuous Flow Chemistry
February 14, 2019
Uniqsis announces its PhotoSyn™ high-power photoreactor light module for continuous flow chemistry is now available with alternativeLED array configurations that makes it compatible with a broader range of photochemical reactions. The availability of 3 new alternative switchable LED configurations (Blue, UVA-Blue and Blue-Green-White) provides chemists with the unique ability to optimally undertake almost any photochemistry reaction. [...]
PAC ROTTERDAM (NL) MOVED TO A BRAND-NEW FACILITY
February 14, 2019
As of February 4, 2019, PAC’s Rotterdam site has moved into a new, high-tech facility in Rotterdam, the Netherlands. At this PAC brand center, the AC Analytical Controls and Antek product lines are developed, produced and tested for customers around the world. After more than 27 years of operation at the same location, the time [...]
Cellectricon to collaborate with world-renowned pain scientists in the EU-funded Bone Pain Network
February 14, 2019
Cellectricon, a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and neurodegenerative disease, is delighted to announce that we will participate in BonePainII, a European Innovative Training Network committed to promote frontline research, innovation and education within bone pain. Millions of Europeans and beyond suffer from bone [...]
February 14, 2019
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) [...]
February 14, 2019
Collaboration Provides Personalised Healthcare Benefits to Patients and Contributes Diverse Data Samples for Research BC Platforms, a global leader in genomic data management and analytics, today announced it is providing its world leading genomics platform to Bumrungrad International, a multi-specialty hospital located in the heart of Bangkok, Thailand handling more than 1.1 million patients per year. [...]
Hach becomes the first global Nereda® certified preferred supplier
February 14, 2019
Loveland, Colo. – (February 2019) – In October 2018, after rigorous testing and analysis at Epe Wastewater Treatment Facility in the Netherlands, Hach’s instrumentation and Prognosys® predictive diagnostic system have been certified by Royal HaskoningDHV and approved for global use with the Nereda® waste water treatment process. This makes Hach the first global Nereda supply partner to have their [...]
February 14, 2019
BOSTON, MA – Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the hiring of Dr. Joseph Krueger as Vice President, Research and Applications for Advanced Pathology Services. Dr. Krueger brings more than 15 years of in vivo and ex vivo experience in [...]
CRISPR/Cas9 Knockout Cell Lines and Lysates
February 14, 2019
AMSBIO has established a comprehensive portfolio of knock-out cell lines and lysates generated with CRISPR/Cas9 technology. Using CRISPR/Cas9 gene editing technology for the generation of knock-out cell lines and cell lysates ensures the development of useful tools to validate antibody specificity and elucidate gene function. Knock-out cell lines and cell lysates are widely agreed to be the [...]
